Please review the Important Disclosure Information set forth in the footer of this website.

07/09/2026

QSBS Rollover: How to Keep the Clock Running Into Your Next Venture

By Dan Magier, CFP® and CAIA®

The acquisition offer arrives at year three. The terms are good (genuinely good), and you want to take it. But you've been counting on QSBS to shelter a significant portion of the gain, and five years is the threshold. You're two years short.

Most founders at this point believe they have two choices: turn down the deal or forfeit the tax benefit. Neither is true, but the option that exists has a 60-day deadline and very specific requirements, which almost never comes up until after the term sheet is signed.

That option is Section 1045, the rollover provision written into the tax code alongside Section 1202. It allows you to sell qualifying stock before the five-year mark, reinvest the proceeds into new QSBS within 60 days, and defer the gain on the original sale. The holding period from your original shares carries over to the replacement shares, so the clock doesn't restart.

This strategy rarely works when founders discover it mid-process; it works when their advisors understand the mechanics before the deal is ever on the table.

Why the 60-Day Window Is Harder Than It Sounds

When you sell QSBS, you have 60 calendar days to close on replacement QSBS. The clock starts on the date of sale. No extensions, no grace periods. The gain deferred on the original sale reduces the basis of the replacement shares dollar-for-dollar—postponed, not erased—and the five-year clock on the replacement shares picks up where the original left off.

The 60-day window is a tax deadline, but the decision inside it is a wealth planning decision. More than filing a form, you're committing a substantial sum to a new investment under time pressure, without the diligence runway you would normally want. Founders who treat Section 1045 as an emergency option tend to find themselves choosing between a bad investment and a missed deadline. The strategy works when the reinvestment target is already identified before the deal closes.

The Section 1045 election must appear on the tax return for the year you sold your original QSBS, not the year you completed the reinvestment. If you sell in November and close on the replacement shares in January, the election belongs on the November year's return, even though the investment happened in the new year. Miss it, and the deferral is gone regardless of whether everything else was done correctly.

What the Replacement Stock Has to Be

The replacement shares must qualify as QSBS under Section 1202 on their own merits: a domestic C corporation, stock acquired at original issuance, company gross assets under $75 million at issuance (for post-OBBBA shares), and an active qualified business for at least 6 months after issuance.

Founders often assume the replacement must be a brand-new company. It doesn't. Rolling proceeds into another early-stage startup, taking a founding position in a co-founder's venture, or investing in a qualifying seed round can each work, provided the shares are original issuances and the company passes the tests.

Founders who want to roll into a company they start themselves can do that too, but the IRS requires genuine operating substance. A legitimate business plan, real activities, and a properly structured C-corporation. Rolling proceeds into a holding company sitting on cash will not survive scrutiny.

Even if they don’t ask it out loud, most founders wonder, What if the replacement company fails? The deferred gain from the original sale is embedded in the basis of the replacement shares, so the outcome depends on that company's trajectory. If the shares become worthless, you may be able to claim a loss under Section 1244, but this is not a consequence-free move. The reinvestment must make sense as an investment, independent of the tax benefit.

What the OBBBA Changed and What It Didn't

The One Big Beautiful Bill Act, signed into law on July 4, 2025, left Section 1045 untouched. What shifted is the landscape around the rollover. Under the pre-OBBBA rules, selling QSBS before five years meant no exclusion at all, so the rollover was the only path. The new tiered schedule for post-OBBBA shares changed that calculus at years three and four, but not across the board.

The table below shows where the rollover remains essential and where a founder with post-OBBBA shares now has more options.

Holding Period

Pre-OBBBA Shares (issued on or before July 4, 2025)

Post-OBBBA Shares (issued after July 4, 2025)

Under 6 months

No exclusion. Rollover not available.

No exclusion. Rollover not available.

6 months to 3 years

No exclusion. Rollover defers the gain.

No exclusion. Rollover defers the gain.

3 to 4 years

No exclusion. Rollover defers the gain.

50% exclusion available. Rollover still the path to 100%.

4 to 5 years

No exclusion. Rollover defers the gain.

75% exclusion available. Rollover still the path to 100%.

5+ years

100% exclusion up to $10M per issuer.

100% exclusion up to $15M per issuer (inflation-adjusted after 2026).

That said, the rollover remains the right tool in specific situations. If you want the full 100% exclusion and can hold replacement shares to the five-year mark, the rollover outperforms a partial exclusion on the original sale. If the gain exceeds the $15 million per-issuer cap, rolling the excess into a second qualifying company defers recognition rather than triggering it. For founders still holding pre-OBBBA shares under the old all-or-nothing framework, the rollover is the only legitimate option for an early exit.

Rolling pre-OBBBA shares into new replacement stock does not upgrade them to the post-OBBBA tiered schedule. The exclusion percentage is tied to the acquisition date of the original shares. The replacement company is evaluated under whichever rules applied when it issued its own shares. That matters for the gross asset cap and per-issuer limit, but it is a separate question from the exclusion percentage.

The Gap That Costs Founders the Most

Founders who miss this window rarely lack good advisors; their advisors likely aren’t talking to each other before the deal closes.

The attorney negotiating the purchase agreement is focused on representations and indemnification. The CPA is managing the tax return. The wealth advisor is often brought in after the term sheet is signed. None of them is independently responsible for flagging that a qualifying reinvestment needs to be identified before the 60-day clock starts.

This is a coordination problem, not a knowledge problem. Section 1045 is well documented. What is harder to find is an advisor who can sit at the intersection of the tax deadline, the investment decision, and the estate planning implications of moving a concentrated gain into a new position, and who runs that coordination proactively rather than reactively.

If you have equity approaching a potential liquidity event before the five-year mark, the time to work through this is before the letter of intent is signed. At Next Capital, we work with founders on exactly this kind of pre-exit planning, coordinating with your existing legal and tax counsel so nothing falls through the cracks.

Frequently Asked Questions About QSBS Rollover

Can I roll QSBS gains into a company I start myself?

Yes, with significant conditions. The replacement company must be a legitimate operating business with genuine activities, a real business plan, and a properly formed C-corporation. Rolling proceeds into a shell holding cash will not qualify. The provision was designed to encourage continued entrepreneurship, and the IRS expects the replacement company to reflect that intent. Work closely with both legal and tax counsel before structuring this; the substance requirement is real and needs to be documented carefully.

What is the minimum holding period before I can use a Section 1045 rollover?

You must have held the original QSBS for more than six months. This is a hard floor with no exceptions. Stock held for six months or less does not qualify for the rollover, regardless of how quickly you reinvest the proceeds or how clean the replacement stock is.

Does a Section 1045 rollover eliminate the tax on my gain?

No. The rollover defers the gain; it doesn't erase it. The deferred amount reduces your basis in the replacement shares. When you eventually sell the replacement stock, that gain will be recognized unless you've held long enough to qualify for the Section 1202 exclusion at that point. If the replacement shares fail or lose value, the deferred gain is still embedded in your basis, which is why the investment decision and the tax decision need to be evaluated together.

Did the OBBBA change the Section 1045 rollover rules?

No. The One Big Beautiful Bill Act, signed July 4, 2025, left Section 1045 unchanged. What changed under the OBBBA is the Section 1202 framework surrounding the rollover: the per-issuer exclusion cap increased to $15 million for post-OBBBA stock (up from $10 million), the gross asset threshold for qualifying companies increased to $75 million (up from $50 million), and a tiered partial exclusion schedule now applies to stock issued after July 4, 2025. The 60-day window and six-month minimum hold are unchanged.

Can I roll into more than one replacement company?

Yes. Section 1045 allows you to split the proceeds across multiple qualifying QSBS issuances, and each company carries its own per-issuer exclusion cap. A founder who rolls into two separate qualifying companies may have access to two distinct exclusion caps when those shares are eventually sold, provided each company independently meets the Section 1202 requirements at that time. The investment rationale for each company has to hold up on its own terms.

Can I roll my QSBS proceeds directly into a venture capital fund or look for a 1045 fund?

Generally, no. A Section 1045 rollover requires you to reinvest your liquidation proceeds directly into replacement stock issued by a qualifying domestic C corporation. Because standard venture capital and private equity funds are structured as pass-through partnerships (LPs or LLCs) rather than C corporations, purchasing an interest in a fund will not satisfy the rollover requirements.

While an investment fund can execute a Section 1045 rollover at the partnership level when the fund sells and reinvests in portfolio companies, an individual investor cannot roll individual exit proceeds into a fund structure. Pre-packaged 1045 QSBS funds designed to absorb individual rollover capital do not exist under current tax law. To keep your clock running, you must deploy the capital directly into a qualifying C corporation's original equity issuance.

About Dan

Dan Magier is a Partner and Managing Director of Wealth Strategy and Advisory at Next Capital Management, where he works with founders, executives, and complex families on pre-liquidity planning, tax strategy, and multigenerational wealth coordination. He holds the CFP® and CAIA® designations and earned a B.A. in Economics from the University of Michigan.

 

 


IMPORTANT DISCLOSURE INFORMATION 

Next Capital Management, LLC (“Company”) is an SEC registered investment adviser located in New York, New York. 

The Company may only transact business in those states in which it is registered, or qualifies for an exemption or exclusion from registration requirements. The Company’s website is limited to the dissemination of general information pertaining to its advisory services, together with access to additional investment-related information, publications, and links. Accordingly, the publication of the Company’s website on the Internet should not be construed by any consumer and/or prospective client as the Company’s solicitation to effect, or attempt to effect transactions in securities, or the rendering of personalized investment advice for compensation, over the Internet. Any subsequent, direct communication by the Company with a prospective client shall be conducted by a representative that is either registered or qualifies for an exemption or exclusion from registration in the state where the prospective client resides. A copy of the Company’s current written disclosure Brochure and Form CRS discussing the Company’s business operations, services, and fees is available on this website and/or from the Company upon written request. The Company does not make any representations or warranties as to the accuracy, timeliness, suitability, completeness, or relevance of any information prepared by any unaffiliated third party, whether linked to the Company’s website or incorporated herein, and takes no responsibility therefor. All such information is provided solely for convenience purposes only and all users thereof should be guided accordingly. 

Please remember that different types of investments involve varying degrees of risk, and there can be no assurance that the future performance of any specific investment or investment strategy (including those undertaken or recommended by the Company), will be profitable or equal any historical performance level(s). Neither the Company’s investment adviser registration status, nor any amount of prior experience or success, should be construed that a certain level of results or satisfaction will be achieved if the Company is engaged, or continues to be engaged, to provide investment advisory services. The Company’s registration status does not imply a specific level of skill or training. 

Certain portions of the Company’s website (i.e., newsletters, articles, commentaries, etc.) may contain a discussion of, and/or provide access to, the Company’s (and those of other investment and non-investment professionals) positions and/or recommendations as of a specific prior date. Due to various factors, including changing market conditions, such discussion may no longer be reflective of current position(s) and/or recommendation(s). Moreover, no client or prospective client should assume that any such discussion serves as the receipt of, or a substitute for, personalized advice from the Company, or from any other investment professional. The Company is neither an attorney nor an accountant, and no portion of the website content should be interpreted as legal, accounting or tax advice. 

Please Note: Limitations. Neither rankings nor recognitions by unaffiliated rating services, publications, media, or other organizations, nor the achievement of any professional designation, certification, degree, or license, membership in any professional organization, or any amount of prior experience or success, should be construed by a client or prospective client as a guarantee that the client will experience a certain level of results if the investment professional or the investment professional’s firm is engaged, or continues to be engaged, to provide investment advisory services. 

To the extent that any client or prospective client utilizes any economic calculator or similar interactive device contained within or linked to the Company’s website, the client and/or prospective client acknowledges and understands that the information resulting from the use of any such calculator/device, is not, and should not be construed, in any manner whatsoever, as the receipt of, or a substitute for, personalized individual advice from the Company, or from any other investment professional. 

Each client and prospective client agrees as a condition precedent to his/her/its access to the Company’s website, to release and hold harmless the Company, its officers, directors, owners, employees and agents from any and all adverse consequences resulting from any of his/her/its actions and/or omissions which are independent of his/her/its receipt of personalized individual advice from the Company.